Follow
David R Matthews
David R Matthews
Professor of Diabetes, University of Oxford
Verified email at ocdem.ox.ac.uk
Title
Cited by
Cited by
Year
Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
DR Matthews, JP Hosker, AS Rudenski, BA Naylor, DF Treacher, ...
Diabetologia 28 (7), 412-419, 1985
337331985
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
UK Prospective Diabetes Study (UKPDS) Group
The lancet 352 (9131), 837-853, 1998
231521998
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton, AI Adler, HAW Neil, DR Matthews, SE Manley, CA Cull, ...
Bmj 321 (7258), 405-412, 2000
115792000
10-year follow-up of intensive glucose control in type 2 diabetes
RR Holman, SK Paul, MA Bethel, DR Matthews, HAW Neil
New England journal of medicine 359 (15), 1577-1589, 2008
93442008
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
UK Prospective Diabetes Study (UKPDS) Group
The Lancet 352 (9131), 854-865, 1998
86371998
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ...
Diabetes care 35 (6), 1364-1379, 2012
6896*2012
Canagliflozin and cardiovascular and renal events in type 2 diabetes
B Neal, V Perkovic, KW Mahaffey, D De Zeeuw, G Fulcher, N Erondu, ...
New England Journal of Medicine 377 (7), 644-657, 2017
56542017
Use and abuse of HOMA modeling
TM Wallace, JC Levy, DR Matthews
Diabetes care 27 (6), 1487-1495, 2004
51672004
Publication bias in clinical research
PJ Easterbrook, R Gopalan, JA Berlin, DR Matthews
The Lancet 337 (8746), 867-872, 1991
33301991
Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ...
Diabetes care 38 (1), 140-149, 2015
32302015
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
AI Adler, IM Stratton, HAW Neil, JS Yudkin, DR Matthews, CA Cull, ...
Bmj 321 (7258), 412-419, 2000
29122000
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)
RC Turner, H Millns, HAW Neil, IM Stratton, SE Manley, DR Matthews, ...
Bmj 316 (7134), 823-828, 1998
28031998
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
UK Prospective Diabetes Study Group
Bmj 317 (7160), 713-720, 1998
21371998
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ...
The Lancet 368 (9541), 1096-1105, 2006
21182006
Correct homeostasis model assessment (HOMA) evaluation uses the computer program
JC Levy, DR Matthews, MP Hermans
Diabetes care 21 (12), 2191, 1998
20971998
UK Prospective Diabetes Study 16: overview of 6 years' therapy of type II diabetes: a progressive disease
UK Prospective Diabetes Study Group
Diabetes 44 (11), 1249-1258, 1995
17791995
Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in …
M Nauck, A Frid, K Hermansen, NS Shah, T Tankova, IH Mitha, ...
Diabetes care 32 (1), 84-90, 2009
14452009
UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis
IM Stratton, EM Kohner, SJ Aldington, RC Turner, RR Holman, SE Manley, ...
Diabetologia 44 (2), 156-163, 2001
11942001
Psychosocial problems and barriers to improved diabetes management: results of the Cross‐National Diabetes Attitudes, Wishes and Needs (DAWN) Study
M Peyrot, RR Rubin, T Lauritzen, FJ Snoek, DR Matthews, SE Skovlund
Diabetic medicine 22 (10), 1379-1385, 2005
10892005
Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations
F Rubino, DM Nathan, RH Eckel, PR Schauer, KGMM Alberti, PZ Zimmet, ...
Diabetes care 39 (6), 861-877, 2016
10202016
The system can't perform the operation now. Try again later.
Articles 1–20